Change Width: wide narrow
Home Clinical Trials Search & Featured Trials

Search Engines - Featured Trials

 

Featured Trials Print

The clinical trials listed on this page should not be construed as being endorsed by HER2 Support Group. You should consult your medical practitioner beforehand if you are interested in participating in any of these trials. Also, these are not the only clinical trials currently available for women who overexpress the HER2/neu gene, but are representative of trials of drugs currently under study. If you are aware of any clinical trials of interest to our group or if you are Healthcare Professional and wish to have a trial listed here please contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

 

Vaccines

University of Washington

Other Trials at U of W

duke1 Vaccine Plus Lapatinib
Glaxo Smith Kline

 

Other Noteworthy Trials

dana Farber
T-DM1 Trials
NCI-logo

BOLERO Trials

Herceptin plus new

Novartis Investigational Drug

Tykerb - Adjuvant Theraphy Trials Other Trials of Interest

infinity1

IPI-504 and Herceptin in Metastatic Breast Cancer. In preclinical studies, IPI-504 has demonstrated the potential to disrupt the activity of multiple proteins and cell signaling pathways implicated in tumor growth, including HER2.

 

The clinical trials listed on this page shoud not be construed as being endorsed by the HER2 Support Group. You should consult your medical practitioner beforehand if you are interested in participating in any of these trials. Also, these are not the only clinical trials currently available for women who overexpress the HER2/neu gene, but are representative of trials of drugs currently under study. If you are aware of any clinical trials of intrest to our group, or if you are a Healthcare Professional and wish to have a trial listed here, please contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Last Updated on Tuesday, 01 February 2011 11:47